Article
A potent MAPK13-14 inhibitor prevents airway inflammation and mucus production
2023-05-27
Abstract excerpt
<h4>ABSTRACT</h4> Common respiratory diseases continue to represent a major public health problem, and much of the morbidity and mortality is due to airway inflammation and mucus production. Previous studies indicated a role for mitogen-activated protein kinase 14 (MAPK14) in this type of disease, but clinical trials are unsuccessful to date. Our previous work identified a related but distinct kinase known as MAP...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 5e6caac7-43d4-5d11-8b2a-09fc913da8c2
- DOI
- 10.1101/2023.05.26.542451
